Icon

ABRAXANE (nda021660)- (100MG/VIAL)

PACLITAXEL BRISTOL-MYERS
100MG/VIAL
Yes Yes
2034-Jul-12 Expired
None None
None No
ABRAXANE™ for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy.
1 0 1
Total Other Developers 3
Drugs with Suitability No
100MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******* ******* *************** **., ***. (******* **** ****) *********** ** ******* ****, ******** & ************* *********** ****,, ***********, ******* ******, ***** (***) ***

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.